Trump picks Dr. Marty Makary as Food and Drug Administration commissioner
‘Tipping the scales’: House GOP leaders rip ActBlue after Dem fundraising giant hit with subpoena
In this situation, it appears that leaders within the Republican party in the House of Representatives are voicing their criticisms of ActBlue, a fundraising tool often used by the Democratic party. Their criticism seems to have been spurred by ActBlue receiving a subpoena, typically a legal demand for documents or testimony related to an investigation. However, without more context, like why ActBlue was subpoenaed or which House GOP leaders are criticizing them, it’s difficult to elaborate much further.